APA

Lin R. J., Lobaugh S. M., Pennisi M., Chan H. T., Batlevi Y., Ruiz J. D., Elko T. A., Maloy M. A., Batlevi C. L., Dahi P. B., Giralt S. A., Hamlin P. A., Mead E., Noy A., Palomba M. L., Santomasso B. D., Sauter C. S., Scordo M., Shah G. L., Korc-Grodzicki B., Kim S. J., Silverberg M. L., Brooklyn C. A., Devlin S. M. & Perales M. (20210521). Impact and safety of chimeric antigen receptor T-cell therapy in older, vulnerable patients with relapsed/refractory large B-cell lymphoma. : Haematologica.

Chicago

Lin Richard J, Lobaugh Stephanie M, Pennisi Martina, Chan Hei Ton, Batlevi Yakup, Ruiz Josel D, Elko Theresa A, Maloy Molly A, Batlevi Connie L, Dahi Parastoo B, Giralt Sergio A, Hamlin Paul A, Mead Elena, Noy Arela, Palomba M Lia, Santomasso Bianca D, Sauter Craig S, Scordo Michael, Shah Gunjan L, Korc-Grodzicki Beatriz, Kim Soo Jung, Silverberg Mari Lynne, Brooklyn Chelsea A, Devlin Sean M and Perales Miguel-Angel. 20210521. Impact and safety of chimeric antigen receptor T-cell therapy in older, vulnerable patients with relapsed/refractory large B-cell lymphoma. : Haematologica.

Harvard

Lin R. J., Lobaugh S. M., Pennisi M., Chan H. T., Batlevi Y., Ruiz J. D., Elko T. A., Maloy M. A., Batlevi C. L., Dahi P. B., Giralt S. A., Hamlin P. A., Mead E., Noy A., Palomba M. L., Santomasso B. D., Sauter C. S., Scordo M., Shah G. L., Korc-Grodzicki B., Kim S. J., Silverberg M. L., Brooklyn C. A., Devlin S. M. and Perales M. (20210521). Impact and safety of chimeric antigen receptor T-cell therapy in older, vulnerable patients with relapsed/refractory large B-cell lymphoma. : Haematologica.

MLA

Lin Richard J, Lobaugh Stephanie M, Pennisi Martina, Chan Hei Ton, Batlevi Yakup, Ruiz Josel D, Elko Theresa A, Maloy Molly A, Batlevi Connie L, Dahi Parastoo B, Giralt Sergio A, Hamlin Paul A, Mead Elena, Noy Arela, Palomba M Lia, Santomasso Bianca D, Sauter Craig S, Scordo Michael, Shah Gunjan L, Korc-Grodzicki Beatriz, Kim Soo Jung, Silverberg Mari Lynne, Brooklyn Chelsea A, Devlin Sean M and Perales Miguel-Angel. Impact and safety of chimeric antigen receptor T-cell therapy in older, vulnerable patients with relapsed/refractory large B-cell lymphoma. : Haematologica. 20210521.